The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil

Suzano, C E S; Amaral, Eliana; Sato, Helena Keico; Papaiordanou, Priscila M. O.

doi:10.1016/j.vaccine.2005.09.033

Cited by 128 publications

(78 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…10,11,23 Protective immunity after YF vaccination. Twelve studies in 11 articles 6,10,[25][26][27][28][29][30][31][32][33] addressed the efficacy of YF vaccine in terms of immunogenicity (Table 3). Seroconversion rates were consistently 90% in 9 of 10 studies.…”

Section: Resultsmentioning

confidence: 99%

“…Interestingly, four of the studies evaluated vaccine performance in the context of mass vaccination campaigns 25,26,29,32 The seroconversion rates in these studies ranged from 89.7% to 98.2%. Moreover, Tavares-Neto and others 29 reported a seroconversion rate of 94% (363 of 387) after a vaccination campaign in a remote region of Brazil, which was characterized by its difficult access, minimally trained personnel, and limited resources.…”

Section: Discussionmentioning

confidence: 99%

“…Only two studies addressed the immunogenicity of YF vaccine in pregnant women. 32,56 These studies reported contrasting results; they showed high seroconversion rates in women vaccinated early in their pregnancy versus low seropositivity after vaccination in their third trimester.…”

Section: Americanmentioning

confidence: 99%

“…32 These women received vaccine at a mean of 5.7 weeks of gestation. In the six weeks after vaccination, 98.2% had neutralizing antibodies.…”

Section: Americanmentioning

confidence: 99%

See 3 more Smart Citations

Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years

Gotuzzo¹,

Yactayo²,

Córdova³

2013

The American Society of Tropical Medicine and Hygiene

200

172

View full text Add to dashboard Cite

Abstract. Current regulations stipulate a yellow fever (YF) booster every 10 years. We conducted a systematic review of the protective efficacy and duration of immunity of YF vaccine in residents of disease-endemic areas and in travelers to assess the need for a booster in these two settings and in selected populations (human immunodeficiency virus-infected persons, infants, children, pregnant women, and severely malnourished persons). Thirty-six studies and 22 reports were included. We identified 12 studies of immunogenicity, 8 of duration of immunity, 8 of vaccine response in infants and children, 7 of human-immunodeficiency virus-infected persons, 2 of pregnant women, and 1 of severely malnourished children. Based on currently available data, a single dose of YF vaccine is highly immunogenic and confers sustained life-long protective immunity against YF. Therefore, a booster dose of YF vaccine is not needed. Special considerations for selected populations are detailed.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Americanmentioning

confidence: 99%

“…32 These women received vaccine at a mean of 5.7 weeks of gestation. In the six weeks after vaccination, 98.2% had neutralizing antibodies.…”

Section: Americanmentioning

confidence: 99%

See 2 more Smart Citations

Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years

Gotuzzo¹,

Yactayo²,

Córdova³

2013

The American Society of Tropical Medicine and Hygiene

200

172

View full text Add to dashboard Cite

show abstract

“…Evidence has suggested a link with early gestational losses and spontaneous abortion. 28,29 However, the yellow fever vaccine may be given during unavoidable travel, or during an epidemic.…”

Section: Precautions and Contraindicationsmentioning

confidence: 99%